Hjem › Eggstokkreft › Washington › Spokane
Kliniske studier for Eggstokkreft i Spokane, WA
8 studier for Eggstokkreft søker deltakere på steder i og rundt Spokane (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
RekruttererFase 3
- Providence Sacred Heart Medical Center & Children's Hospital, Spokane
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RekruttererFase 2
- Providence Sacred Heart Medical Center & Children'S Hospital /ID# 274585, Spokane
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
RekruttererFase 1/2
- Providence Sacred Heart Medical Center, Spokane
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
RekruttererFase 3
- Providence Sacred Heart Medical Center & Children's Hospital, Spokane
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Rekrutterer
- Cancer Care Northwest - Spokane South, Spokane
- Cancer Care Northwest-Valley, Spokane
- Cancer Care Northwest-North Spokane, Spokane
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruttererFase 3
- Cancer Care Northwest - Spokane South, Spokane
- Cancer Care Northwest-Valley, Spokane
- Cancer Care Northwest-North Spokane, Spokane
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RekruttererFase 1/2
- Summit Cancer Centers, Spokane
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
RekruttererFase 2
- USA07-0, Spokane
Eggstokkreft-studier i andre byer
- Houston, TX89 studier
- New York City, NY69 studier
- Boston, MA61 studier
- Los Angeles, CA50 studier
- Nashville, TN49 studier
- Arlington, VA46 studier
- Philadelphia, PA44 studier
- Columbus, OH39 studier
- St. Louis, MO38 studier
- Chicago, IL36 studier
- San Antonio, TX31 studier
- Cleveland, OH30 studier
Andre studier i Spokane
- Ikke-småcellet lungekreft12 studier
- Brystkreft8 studier
- Kolorektal kreft8 studier
- Parkinsons sykdom7 studier
- Kreft (alle typer)6 studier
- Plateepitelcancer i hode og hals6 studier
- Prostatakreft6 studier
- Kronisk lymfatisk leukemi6 studier
- Makuladegenerasjon5 studier
- Melanom5 studier
- Tripelnegativ brystkreft5 studier
- Geografisk atrofi5 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.